|
US4684620A
(en)
|
1984-09-04 |
1987-08-04 |
Gibson-Stephens Neuropharmaceuticals, Inc. |
Cyclic polypeptides having mu-receptor specificity
|
|
US4724229A
(en)
|
1986-09-30 |
1988-02-09 |
Smithkline Beckman Corporation |
Arg-arg-arg-vasopressin antagonists
|
|
US5192746A
(en)
|
1990-07-09 |
1993-03-09 |
Tanabe Seiyaku Co., Ltd. |
Cyclic cell adhesion modulation compounds
|
|
CA2106314A1
(en)
|
1991-04-05 |
1992-10-06 |
John P. Burnier |
Platelet aggregation inhibitors having high specification for gpiibiiia
|
|
AU673731B2
(en)
|
1993-06-03 |
1996-11-21 |
Banyu Pharmaceutical Co., Ltd. |
Novel endothelin antagonistic peptide
|
|
US6037324A
(en)
|
1996-01-04 |
2000-03-14 |
Leukosite, Inc. |
Inhibitors of MAdCAM-1-mediated interactions and methods of use therefor
|
|
US5990084A
(en)
|
1996-04-19 |
1999-11-23 |
Novo Nordisk A/S |
Compounds with growth hormone releasing properties
|
|
GB9613112D0
(en)
|
1996-06-21 |
1996-08-28 |
Zeneca Ltd |
Chemical compounds
|
|
US7122623B2
(en)
*
|
1996-07-12 |
2006-10-17 |
Adherex Technologies, Inc. |
Compounds and methods for modulating cell adhesion
|
|
IL128332A0
(en)
|
1996-08-30 |
2000-01-31 |
Novo Nordisk As |
GLP-1 derivatives
|
|
US5942492A
(en)
|
1996-11-12 |
1999-08-24 |
Angstrom Pharmaceuticals, Inc. |
Cyclic peptides that bind to urokinase-type plasminogen activator receptor
|
|
JP2001509493A
(ja)
|
1997-07-11 |
2001-07-24 |
インナーダイン， インコーポレイテッド |
放射送達構造体の調製およびシール化のための方法およびシステム
|
|
US6818617B1
(en)
|
1997-08-15 |
2004-11-16 |
Temple University- Of The Commonwealth System Of Higher Education |
EC-3, an inhibitor of α4β1 and α4β7 integrins
|
|
JP2001523711A
(ja)
|
1997-11-24 |
2001-11-27 |
メルク エンド カムパニー インコーポレーテッド |
細胞接着阻害薬としての環状アミノ酸誘導体
|
|
JP2002524108A
(ja)
|
1998-07-28 |
2002-08-06 |
インナーダイン， インコーポレイテッド |
吸収性近接照射療法および化学療法送達デバイスならびに方法
|
|
WO2000009560A2
(en)
|
1998-08-17 |
2000-02-24 |
Abgenix, Inc. |
Generation of modified molecules with increased serum half-lives
|
|
US6087334A
(en)
|
1998-08-21 |
2000-07-11 |
Amylin Pharmaceuticals, Inc. |
Anti-diabetic peptides
|
|
AUPP616598A0
(en)
|
1998-09-25 |
1998-10-15 |
University Of Queensland, The |
Auxiliary for amide bond formation
|
|
AUPP616498A0
(en)
|
1998-09-25 |
1998-10-15 |
University Of Queensland, The |
Synthesis of cyclic peptides
|
|
AUPP660698A0
(en)
|
1998-10-21 |
1998-11-12 |
University Of Queensland, The |
A method of protein engineering
|
|
US6451987B1
(en)
|
1999-03-15 |
2002-09-17 |
Novo Nordisk A/S |
Ion exchange chromatography of proteins and peptides
|
|
HUP0200297A3
(en)
|
1999-03-17 |
2002-09-30 |
Novo Nordisk As |
Method for acylating peptides and the glutaminic acid derivatives as acylating agents
|
|
EP1183254B1
(en)
|
1999-04-12 |
2005-01-12 |
Aventis Pharma Limited |
Substituted bicyclic heteroaryl compounds as integrin antagonists
|
|
WO2001068586A2
(en)
|
2000-03-14 |
2001-09-20 |
Novartis Ag |
α4β1 AND α4β7 INTEGRIN INHIBITORS
|
|
WO2002055106A2
(en)
|
2001-01-09 |
2002-07-18 |
Merck Patent Gmbh |
Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors
|
|
DE10107707A1
(de)
|
2001-02-19 |
2002-08-29 |
Wilex Biotechnology Gmbh |
Antagonisten für alpha¶4¶beta¶7¶-Integrin
|
|
AUPS039702A0
(en)
|
2002-02-08 |
2002-03-07 |
University Of Queensland, The |
Common protein surface shapes and uses therefor
|
|
US20030166138A1
(en)
|
2002-02-21 |
2003-09-04 |
Todd Kinsella |
Cyclic peptides and analogs useful to treat allergies
|
|
JP2005533855A
(ja)
|
2002-07-24 |
2005-11-10 |
インターツェル・アクチェンゲゼルシャフト |
病原性ウイルスからの別のリーディングフレームによりコードされる抗原
|
|
US20040176293A1
(en)
|
2002-12-18 |
2004-09-09 |
Wyeth |
Methods for screening, treating and diagnosing inflammatory bowel disease and compositions thereof
|
|
US20070032417A1
(en)
|
2002-12-24 |
2007-02-08 |
Walter And Eliza Hall Institute Of Medical Research |
Peptides and therapeutic uses thereof
|
|
EP1618131A2
(en)
|
2003-04-15 |
2006-01-25 |
Xenon Pharmaceuticals Inc. |
Juvenile hemochromatosis gene (hfe2a), expression products and uses thereof
|
|
WO2005044839A2
(en)
|
2003-11-05 |
2005-05-19 |
Dana-Farber Cancer Institute, Inc. |
Stabilized alpha helical peptides and uses thereof
|
|
EP1695255B1
(en)
|
2003-12-19 |
2016-09-07 |
Applied Biosystems, LLC |
Methods and systems for protein and peptide evidence assembly
|
|
PL2177537T3
(pl)
|
2004-01-09 |
2012-06-29 |
Pfizer |
Przeciwciała przeciw MadCAM
|
|
US8536140B2
(en)
|
2004-03-12 |
2013-09-17 |
Mti Meta Tech Inc. |
Methods for treating inflammatory bowel disease
|
|
US20070197430A1
(en)
|
2004-06-24 |
2007-08-23 |
Jonathan Baell |
Conjugates And Therapeutic Uses Thereof
|
|
CA2581319A1
(en)
|
2004-09-23 |
2006-03-30 |
The University Of Melbourne |
Antigenic complex for the diagnosis and treatment of porphyromonas gingivalis infection
|
|
WO2006062685A2
(en)
|
2004-11-11 |
2006-06-15 |
Affymax, Inc. |
Novel peptides that bind to the erythropoietin receptor
|
|
JP2008521840A
(ja)
|
2004-11-30 |
2008-06-26 |
ガストロテック・ファルマ・アクティーゼルスカブ |
成長ホルモン分泌促進物質レセプター１ａリガンド
|
|
US20100183617A1
(en)
|
2005-02-23 |
2010-07-22 |
University Of Virginia Patent Foundation |
Compositions and methods for regulating sas1r
|
|
US7534764B2
(en)
|
2005-06-29 |
2009-05-19 |
The Regents Of The University Of California |
Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin
|
|
US8076306B2
(en)
|
2006-04-12 |
2011-12-13 |
Isis Pharmaceuticals, Inc. |
Compositions and their uses directed to hepcidin
|
|
GB0610395D0
(en)
|
2006-05-25 |
2006-07-05 |
Ge Healthcare Ltd |
Novel imaging agents
|
|
CA2655372A1
(en)
|
2006-06-13 |
2007-12-21 |
Zymogenetics, Inc. |
Il-17 and il-23 antagonists and methods of using the same
|
|
US20080019913A1
(en)
|
2006-07-07 |
2008-01-24 |
University Of Arizona Office Of Technology Transfer |
Enkepahlin analogs with improved bioavailability
|
|
WO2008045252A2
(en)
|
2006-10-04 |
2008-04-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Engineered integrin binding peptides
|
|
US7713937B2
(en)
|
2006-11-10 |
2010-05-11 |
Cara Therapeutics, Inc. |
Synthetic peptide amides and dimeric forms thereof
|
|
US9193790B2
(en)
|
2006-12-07 |
2015-11-24 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Use of antagonists of the interaction between HIV GP120 and A4B7 integrin
|
|
TW200900420A
(en)
|
2007-02-02 |
2009-01-01 |
Amgen Inc |
Hepcidin, hepcidin antagonists and methods of use
|
|
US8293883B2
(en)
|
2007-02-23 |
2012-10-23 |
Schering Corporation |
Engineered anti-IL-23P19 antibodies
|
|
US20080260820A1
(en)
|
2007-04-19 |
2008-10-23 |
Gilles Borrelly |
Oral dosage formulations of protease-resistant polypeptides
|
|
EP2150564A2
(en)
|
2007-04-27 |
2010-02-10 |
ZymoGenetics, Inc. |
Antagonists to il-17a, il-17f, and il-23p19 and methods of use
|
|
WO2008144041A1
(en)
|
2007-05-21 |
2008-11-27 |
The Ohio State University Research Foundation |
Hepcidins as biomarkers for impending lupus nephritis flare
|
|
WO2009002947A2
(en)
|
2007-06-22 |
2008-12-31 |
Affymax, Inc. |
Compounds and peptides that bind the trail receptor
|
|
EP2288621A4
(en)
|
2007-07-06 |
2012-01-04 |
Valorisation Hsj Soc En Commandite |
IL23 RECEPTOR ANTAGONISTS AND THEIR USE
|
|
CN101358201A
(zh)
|
2007-07-31 |
2009-02-04 |
钱忠明 |
重组人铁调素腺病毒、其制备方法及应用
|
|
CN101307085B
(zh)
|
2007-08-01 |
2012-06-13 |
香港理工大学深圳研究院 |
抑制铁调素调节蛋白的siRNA、重组慢病毒及其应用
|
|
CA2707840A1
(en)
|
2007-08-20 |
2009-02-26 |
Allozyne, Inc. |
Amino acid substituted molecules
|
|
GR1006896B
(el)
|
2007-08-24 |
2010-07-20 |
Ελληνικο Ινστιτουτο Παστερ, |
Μεθοδος παραγωγης μιας πεπτιδικης ορμονης
|
|
WO2009039185A1
(en)
|
2007-09-17 |
2009-03-26 |
The Trustees Of Columbia University In The City Of New York |
Uses of immunologically modified scaffold for tissue prevascularization and cell transplantation
|
|
US20100280098A1
(en)
|
2007-10-05 |
2010-11-04 |
Juliano Rudolph L |
Receptor targeted oligonucleotides
|
|
AU2009322260B2
(en)
|
2008-12-05 |
2013-09-12 |
The Regents Of The University Of California |
Mini-hepcidin peptides and methods of using thereof
|
|
DE102009007381A1
(de)
|
2009-01-29 |
2010-08-05 |
Amp-Therapeutics Gmbh & Co. Kg |
Antibiotische Peptide
|
|
US8999935B2
(en)
|
2009-02-11 |
2015-04-07 |
New York University |
Treatment of osteoporosis in peri- and post-menopausal women with hepcidin
|
|
EP2418213B1
(en)
|
2009-04-08 |
2014-11-19 |
Takeda Pharmaceutical Company Limited |
Neuromedin u derivative
|
|
TWI578992B
(zh)
|
2009-04-30 |
2017-04-21 |
諾克森製藥股份有限公司 |
與鐵調節激素（ｈｅｐｃｉｄｉｎ）結合之核酸類
|
|
EP2733150A1
(en)
|
2010-01-25 |
2014-05-21 |
Cornell University |
Aromatic-cationic peptides and uses of same
|
|
US10416172B2
(en)
|
2010-03-31 |
2019-09-17 |
Medical Diagnostic Laboratories, Llc |
Recombinant soluble truncated IL-23 receptor (IL-23R) capable of inhibiting IL-23R-mediated cell signaling
|
|
JP2011231085A
(ja)
|
2010-04-30 |
2011-11-17 |
Osaka Prefecture Univ |
環状ペプチド
|
|
WO2011149942A2
(en)
|
2010-05-24 |
2011-12-01 |
Children's Medical Center Corporation |
Compositions and methods for plasma peptide analysis
|
|
RS59978B1
(sr)
|
2010-08-11 |
2020-03-31 |
Ironwood Pharmaceuticals Inc |
Stabilne formulacije linaklotida
|
|
EP2444101A1
(en)
|
2010-10-21 |
2012-04-25 |
Universitätsklinikum Freiburg |
Selective targeting of the CD40L/Mac-1 interaction by small peptide inhibitors and its use for the treatment of inflammation and atherogenesis
|
|
EP2668199B1
(en)
|
2011-01-27 |
2017-09-06 |
Ramot at Tel Aviv University, Ltd. |
Glycogen synthase kinase-3 inhibitors
|
|
US9605027B2
(en)
|
2011-06-14 |
2017-03-28 |
Medical Diagnostic Laboratories, Llc |
Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
|
|
US9169292B2
(en)
|
2011-06-14 |
2015-10-27 |
Medical Diagnostic Laboratories, Llc |
Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
|
|
US8946150B2
(en)
|
2011-06-14 |
2015-02-03 |
Medical Diagnostic Laboratories, LLC. |
Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
|
|
HK1197028A1
(en)
|
2011-06-14 |
2015-01-02 |
Stealth Peptides International, Inc. |
Aromatic-cationic peptides and uses of same
|
|
HK1199892A1
(en)
|
2011-12-09 |
2015-07-24 |
The Regents Of The University Of California |
Modified mini-hepcidin peptides and methods of using thereof
|
|
US20150157692A1
(en)
|
2012-05-23 |
2015-06-11 |
The University Of Chicago |
Methods of treating obesity
|
|
US9273093B2
(en)
*
|
2012-10-11 |
2016-03-01 |
Protagonist Therapeutics, Inc. |
α4β7 peptide dimer antagonists
|
|
EP2956154A4
(en)
|
2013-02-15 |
2016-07-27 |
Srx Cardio Llc |
TYPE 9 (PCSK9) PROPYTEIN CONVERTASE SUBTILISINE / KEXINE PROPAGINE CONVERTASE BINDING LIGANDS FOR USE IN MODULATION OF SERIES LEVELS OF LOW DENSITY LIPOPROTEIN (LDL)
|
|
SI2968443T1
(sl)
|
2013-03-15 |
2022-01-31 |
Protagonist Therapeutics, Inc. |
Analogi hepcidina in njihova uporaba
|
|
US20140294901A1
(en)
|
2013-04-02 |
2014-10-02 |
Protagonist Therapeutics, Inc. |
Novel a4b7 peptide dimer antagonists
|
|
US20140294902A1
(en)
|
2013-04-02 |
2014-10-02 |
Protagonist Therapeutics, Inc. |
Novel a4b7 peptide antagonists
|
|
JP6401255B2
(ja)
|
2013-06-24 |
2018-10-10 |
株式会社 キャンバス |
ペプチド及びペプチド模倣物の併用並びに癌患者亜集団の処置
|
|
WO2014210056A1
(en)
|
2013-06-27 |
2014-12-31 |
Stealth Peptides International, Inc. |
Peptide therapeutics and methods for using same
|
|
CA2926685A1
(en)
|
2013-10-09 |
2015-04-16 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for downregulation of pro-inflammatory cytokines
|
|
US9284362B2
(en)
|
2014-01-22 |
2016-03-15 |
Wisconsin Alumni Research Foundation |
α/β-peptide mimics of Z-domain peptides
|
|
US9315545B2
(en)
|
2014-04-07 |
2016-04-19 |
Merganser Biotech, Inc. |
Hepcidin mimetic peptides and uses thereof
|
|
KR102787208B1
(ko)
|
2014-05-16 |
2025-03-27 |
프로타고니스트 테라퓨틱스, 인코포레이티드 |
α4β7 인테그린 티오에테르 펩티드 길항제
|
|
WO2015183963A2
(en)
|
2014-05-28 |
2015-12-03 |
Stealth Peptides International, Inc. |
Therapeutic compositions including redox-active parabenzoquinones and uses thereof
|
|
CN107075574A
(zh)
|
2014-06-27 |
2017-08-18 |
领导医疗有限公司 |
铁调素和微型铁调素类似物及其用途
|
|
WO2016004093A2
(en)
|
2014-07-01 |
2016-01-07 |
Stealth Biotherapeutics Corp |
Therapeutic compositions including galectin-3 inhibitors and uses thereof
|
|
CN107206254B
(zh)
|
2014-07-17 |
2021-08-24 |
领导医疗有限公司 |
白细胞介素-23受体的口服肽抑制剂以及其治疗炎症性肠病的用途
|
|
US9809623B2
(en)
|
2014-10-01 |
2017-11-07 |
Protagonist Therapeutics, Inc. |
α4β7 peptide monomer and dimer antagonists
|
|
US10301371B2
(en)
|
2014-10-01 |
2019-05-28 |
Protagonist Therapeutics, Inc. |
Cyclic monomer and dimer peptides having integrin antagonist activity
|
|
WO2016109363A1
(en)
|
2014-12-29 |
2016-07-07 |
The Regents Of The University Of California |
S-Alkylated Hepcidin Peptides and Methods of Making and Using Thereof
|
|
US20160199437A1
(en)
|
2015-01-08 |
2016-07-14 |
D. Travis Wilson |
Therapeutic compositions including iron chelators and uses thereof
|
|
US20170369871A1
(en)
|
2015-01-12 |
2017-12-28 |
Synthorx, Inc. |
Incorporation of unnatural nucleotides and methods thereof
|
|
US20160228491A1
(en)
|
2015-02-09 |
2016-08-11 |
Stealth Biotherapeutics Corp |
Therapeutic compositions including phenazine-3-one and phenothiazine-3-one derivatives and uses thereof
|
|
WO2016195663A1
(en)
|
2015-06-02 |
2016-12-08 |
Stealth Peptides International, Inc. |
Therapeutic compositions including bpm 31510, variants and analogues thereof, and uses thereof
|
|
WO2016200364A1
(en)
|
2015-06-08 |
2016-12-15 |
Stealth Peptides International, Inc. |
THERAPEUTIC COMPOSITIONS INCLUDING SkQ COMPOUNDS AND USES THEREOF
|
|
BR112018000691A2
(pt)
|
2015-07-15 |
2018-09-18 |
Protagonist Therapeutics Inc |
inibidores peptídicos do receptor de interleucina-23 e seu uso para tratar doenças inflamatórias
|
|
US10787490B2
(en)
|
2015-07-15 |
2020-09-29 |
Protaganist Therapeutics, Inc. |
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
|
|
US20190002503A1
(en)
|
2015-12-30 |
2019-01-03 |
Protagonist Therapeutics, Inc. |
Analogues of hepcidin mimetics with improved in vivo half lives
|
|
CA3017926C
(en)
|
2016-03-23 |
2023-10-10 |
Protagonist Therapeutics, Inc. |
Methods for synthesizing .alpha.4.beta.7 peptide antagonists
|
|
WO2018022937A1
(en)
|
2016-07-27 |
2018-02-01 |
Protagonist Therapeutics, Inc. |
Peptide inhibitors of interleukin-23 and their use to treat inflammatory diseases
|
|
WO2018089693A2
(en)
|
2016-11-09 |
2018-05-17 |
Protagonist Therapeutics, Inc. |
Methods for determining and monitoring gastrointestinal inflammation
|
|
EP3570864A4
(en)
|
2017-01-18 |
2020-12-30 |
Protagonist Therapeutics, Inc. |
PEPTIDES OF INTERLEUKIN-23 RECEPTOR INHIBITORS AND THEIR USE TO TREAT INFLAMMATORY DISEASES
|
|
EP3681900A4
(en)
|
2017-09-11 |
2021-09-08 |
Protagonist Therapeutics, Inc. |
OPIOID AGONIST PEPTIDES AND THEIR USES
|
|
EP4501952A3
(en)
|
2018-02-08 |
2025-04-16 |
Protagonist Therapeutics, Inc. |
Conjugated hepcidin mimetics
|
|
EP3810094A1
(en)
|
2018-06-20 |
2021-04-28 |
Progenity, Inc. |
Treatment of a disease of the gastrointestinal tract with a jak or other kinase inhibitor
|
|
TW202019948A
(zh)
|
2018-07-12 |
2020-06-01 |
美商領導醫療有限公司 |
介白素-23受體之肽抑制劑及其治療發炎疾病之用途
|
|
WO2021007433A1
(en)
|
2019-07-10 |
2021-01-14 |
Protagonist Therapeutics, Inc. |
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
|